Drugs / RENCA macrobeads
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02046174 | Apr 2014 → Oct 2018 | colorectal carcinoma | The Rogosin Institute | Completed | No outcome recorded |
| Phase 2 | NCT01053013 | Apr 2010 → Apr 2016 | colorectal cancer, pancreatic adenocarcinoma | The Rogosin Institute | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RENCA macrobeads | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01053013 ↗ |
| Known as | mouse renal adenocarcinoma (RENCA) macrobeads | “mouse renal adenocarcinoma (RENCA) macrobeads” NCT01053013 ↗ |
| Route | Other | “implanted intraperitoneally” NCT01053013 ↗ |